Open AccessAre mutations in K-RAS, BRAF and PIK3CA genes critical for response to adjuvant trastuzumab treatment in patients with HER-2 positive breast cancer?
Author(s) -
Anne Marie Bak Jylling,
Anders Aamann Rasmussen,
Erik Jakobsen,
René dePont Christensen,
Flemming Brandt Sørensen
Publication year - 2014
Publication title -
journal of cancer therapeutics and research
Language(s) - English
Resource type - Journals
ISSN - 2049-7962
DOI - 10.7243/2049-7962-3-3
Subject(s) - trastuzumab , medicine , breast cancer , oncology , adjuvant , mutation , gene mutation , cancer , cancer research , gene , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom